Comparison of the Racial/Ethnic Prevalence of Regular Aspirin Use for the Primary Prevention of Coronary Heart Disease from the Multi-Ethnic Study of Atherosclerosis
Daniel R. Sanchez, Ana V. Diez Roux, Erin D. Michos, Roger S. Blumenthal, Pamela J. Schreiner, Gregory L. Burke and Karol Watson
The American journal of cardiology, v 107(1), pp 41-46
Cardiac & Cardiovascular Systems Cardiovascular System & Cardiology Life Sciences & Biomedicine Science & Technology
In 2002, the United States Preventive Services Task Force and the American Heart Association recommended aspirin for the primary prevention of coronary heart disease in patients with Framingham risk scores >= 6% and >= 10%, respectively. The regular use of aspirin (>= 3 days/week) was examined in a cohort of 6,452 White, Black, Hispanic, and Chinese patients without cardiovascular disease in 2000 to 2002 and 5,181 patients from the same cohort in 2005 to 2007. Framingham risk scores were stratified into low (< 6%), increased (6% to 9.9%), and high (>= 10%) risk. In 2000 to 2002 prevalences of aspirin use were 18% and 27% for those at increased and high risk, respectively. Whites (25%) used aspirin more than Blacks (14%), Hispanics (12%), or Chinese (14%) in the increased-risk group (p < 0.001). Corresponding prevalences for the high-risk group were 38%, 25%, 17%, and 21%, respectively (p < 0.001). In 2005 to 2007 prevalences of aspirin use were 31% and 44% for those at increased and high risk, respectively. Whites (41%) used aspirin more than Blacks (27%), Hispanics (24%), or Chinese (15%) in the increased-risk group (p < 0.001). Corresponding prevalences for the high-risk group were 53%, 43%, 38%, and 28%, respectively (p < 0.001). Racial/ethnic differences persisted after adjustment for age, gender, diabetes, income, and education. In conclusion, regular aspirin use in adults at increased and high risk for coronary heart disease remains suboptimal. Important racial/ethnic disparities exist for unclear reasons. (c) 2011 Elsevier Inc. All rights reserved. (Am J Cardiol 2011;107:41-46)
Comparison of the Racial/Ethnic Prevalence of Regular Aspirin Use for the Primary Prevention of Coronary Heart Disease from the Multi-Ethnic Study of Atherosclerosis
Creators
Daniel R. Sanchez - University of California, Los Angeles
Ana V. Diez Roux - University of Michigan
Erin D. Michos - Johns Hopkins Ciccarone Center for the Prevention of Heart Disease; Baltimore, Maryland
Roger S. Blumenthal - Johns Hopkins Ciccarone Center for the Prevention of Heart Disease; Baltimore, Maryland
Pamela J. Schreiner - University of Minnesota
Gregory L. Burke - Wake Forest University
Karol Watson - University of California, Los Angeles
Publication Details
The American journal of cardiology, v 107(1), pp 41-46
Publisher
Elsevier
Number of pages
6
Grant note
N01-HC-95159; N01-HC-95160; N01-HC-95161; N01-HC-95162; N01-HC-95163; N01-HC-95164; N01-HC-95165; N01-HC-95166 / National Heart, Lung, and Blood Institute, Bethesda, Maryland; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)
N01HC095165 / DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)
R13HL095166 / NATIONAL HEART, LUNG, AND BLOOD INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)
Resource Type
Journal article
Language
English
Academic Unit
Urban Health Collaborative; Drexel University
Web of Science ID
WOS:000286126900008
Scopus ID
2-s2.0-78650132509
Other Identifier
991020112078304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: